Advertisement
Exercise and Nutrition in Persons with Dementia Review Article| Volume 21, ISSUE 10, P1410-1414.e2, October 2020

Download started.

Ok

The Impact of Pharmacologic and Nonpharmacologic Interventions to Improve Physical Health Outcomes in People With Dementia: A Meta-Review of Meta-Analyses of Randomized Controlled Trials

Published:February 18, 2020DOI:https://doi.org/10.1016/j.jamda.2020.01.010

      Abstract

      Objectives

      We summarized and compared meta-analyses of pharmacologic and nonpharmacologic interventions targeting physical health outcomes among people with dementia.

      Design

      This is a systematic review and meta-analysis.

      Setting and Participants

      People with dementia, confirmed through validated assessment measures.

      Methods

      Major databases were searched until October 21, 2019. Effect sizes [standardized mean difference (SMD)/Hedges g or risk ratio (RR)] were compared separately.

      Results

      Of 3773 search engine hits, 4 meta-analyses were included, representing 31 meta-analyzed trials and 10,054 study participants. Although meta-analyses were generally of adequate high quality, meta-analyzed studies were less so. Nutritional supplements were the only one to show a weight-increasing effect [SMD 0.53, 95% confidence interval (CI) 0.38–0.68, ie, medium effect; N = 12, n = 748]. Acetylcholinesterase inhibitors are associated with an increased risk for weight loss (RR 2.1, 95% CI 1.5‒3.0; N = 9, n = 7010). For the treatment of pain, sensory stimulation has a medium effect (SMD –0.58, 95% CI –0.99 to −0.17; N = 6, n = 199), whereas physical activity has a small effect (SMD –0.24, 95% CI –1.06 to 0.59; N = 2, n = 75). When exploring the characteristics of the psychosocial interventions, group-based interventions demonstrated a medium (SMD –0.55, 95% CI –1.02 to −0.09; N = 6, n = 157) and individual psychosocial interventions a small effect (SMD –0.27, 95% CI –1.06 to 0.53; N = 2, n = 55).

      Conclusions and Implications

      Despite frequent physical comorbidities, the current evidence for pharmacologic and nonpharmacologic interventions in people with dementia to prevent and treat these conditions is still in its infancy, and larger trials targeting a wide range of physical health outcomes are urgently needed. Based on the SMDs and RRs, nutritional supplements can be recommended as an intervention to treat malnutrition. Clinicians should be careful in treating patients with acetylcholinesterase inhibitors, as it shows medium weight reducing effects. For the treatment of comorbid pain, sensory stimulation and psychosocial interventions are recommended.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kaczynski A.
        • Michalowsky B.
        • Eichler T.
        • et al.
        Comorbidity in dementia diseases and associated health care resources utilization and cost.
        J Alzheimers Dis. 2019; 68: 635-646
        • Vogelgsang J.
        • Wolff-Menzler C.
        • Kis B.
        • et al.
        Cardiovascular and metabolic comorbidities in patients with Alzheimer's disease and vascular dementia compared to a psychiatric control cohort.
        Psychogeriatrics. 2018; 18: 393-401
        • van Kooten J.
        • Binnekade T.T.
        • van der Wouden J.C.
        • et al.
        A review of pain prevalence in Alzheimer's, vascular, frontotemporal and Lewy body dementias.
        Dement Geriatr Cogn Disord. 2016; 41: 220-232
        • Sharma S.
        • Mueller C.
        • Stewart R.
        • et al.
        Predictors of falls and fractures leading to hospitalization in people with dementia: A representative cohort study.
        J Am Med Dir Assoc. 2018; 19: 607-612
        • Deardorff W.J.
        • Liu P.L.
        • Sloane R.
        • et al.
        Association of sensory and cognitive impairment with healthcare utilization and cost in older adults.
        J Am Geriatr Soc. 2019; 67: 1617-1624
        • Salber P.R.
        • Selecky C.E.
        • Soenksen D.
        • Wilson T.
        Impact of dementia on costs of modifiable comorbid conditions.
        Am J Manag Care. 2018; 24: e344-e351
        • Santos C.Y.
        • Snyder P.J.
        • Wu W.‒C.
        • et al.
        Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis.
        Alzheimers Dement (Amst). 2017; 7: 69-87
        • Snowden M.B.
        • Steinman L.E.
        • Bryant L.L.
        • et al.
        Dementia and co-occurring chronic conditions: A systematic literature review to identify what is known and where are the gaps in the evidence?.
        Int J Geriatr Psychiatry. 2017; 32: 357-371
        • Clodomiro A.
        • Gareri P.
        • Puccio G.
        • et al.
        Somatic comorbidities and Alzheimer’s disease treatment.
        Neurol Sci. 2013; 34: 1581-1589
        • Sorbi S.
        • Hort J.
        • Erkinjuntti T.
        • et al.
        EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia.
        Eur J Neurol. 2012; 19: 1159-1179
        • Droogsma E.
        • Van Asselt D.
        • De Deyn P.
        Weight loss and undernutrition in community-dwelling patients with Alzheimer’s dementia.
        Gerontol Geriatr. 2015; 48: 318-324
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • Altman D.G.
        Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.
        PLoS Med. 2009; 6: e1000097
        • Cohen J.
        Statistical Power Analysis for the Behavioral Sciences.
        Lawrence Erlbaum, New York1988
        • Shea B.J.
        • Hamel C.
        • Wells G.A.
        • et al.
        AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews.
        J Clin Epidemiol. 2009; 62: 1013-1020
        • Correll C.U.
        • Rubio J.M.
        • Inczedy‒Farkas G.
        • et al.
        Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: Systematic overview and quality appraisal of the meta-analytic evidence.
        JAMA Psychiatr. 2017; 74: 675-684
        • Higgins J.P.T.
        • Thompson S.G.
        • Deeks J.J.
        • Altman D.G.
        Measuring inconsistency in meta-analyses.
        BMJ. 2003; 327: 557-560
        • Allen V.J.
        • Methven L.
        • Gosney M.A.
        Use of nutritional complete supplements in older adults with dementia: Systematic review and meta-analysis of clinical outcomes.
        Clin Nutr. 2013; 32: 950-957
        • Pu L.
        • Moyle W.
        • Jones C.
        • Todorovic M.J.
        Psychosocial interventions for pain management in older adults with dementia: A systematic review of randomized controlled trials.
        J Adv Nur. 2019; 75: 1608-1620
        • Herke M.
        • Fink A.
        • Langer G.
        • et al.
        Environmental and behavioural modifications for improving food and fluid intake in people with dementia.
        Cochrane Database Syst Rev. 2018; 7: CD011542
        • Soysal P.
        • Isik A.T.
        • Stubbs B.
        • et al.
        Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: A systematic review and meta-analysis.
        J Neurol Neurosurg Psychiatry. 2016; 87: 1368-1374
        • Saka B.
        • Kaya O.
        • Ozturk G.B.
        • et al.
        Malnutrition in the elderly and its relationship with other geriatric syndromes.
        Clin Nutr. 2010; 29: 745-748
        • Naseer M.
        • Forssell H.
        • Fagerström C.
        Malnutrition, functional ability and mortality among older people aged ≥60 years: A 7‒year longitudinal study.
        Eur J Clin Nutr. 2016; 70: 399
        • Lam B.
        • Hollingdrake E.
        • Kennedy J.L.
        • et al.
        Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: The emerging pharmacogenetic story.
        Hum Genomics. 2009; 4: 91
        • Yalom I.D.
        Inpatient Group Psychotherapy.
        Basic Books, New York City, NY1983
        • Scott I.
        • Cooper C.
        • Leverton M.
        • et al.
        Effects of nonpharmacological interventions on functioning of people living with dementia at home: A systematic review of randomised controlled trials.
        Int J Geriatr Psychiatry. 2019; 34: 1386-1402

      Included meta-analyses

        • Herke M.
        • Fink A.
        • Langer G.
        • et al.
        Environmental and behavioural modifications for improving food and fluid intake in people with dementia.
        Cochrane Database Syst Rev. 2018; 7: CD011542
        • Pu L.
        • Moyle W.
        • Jones C.
        • Todorovic M.
        Psychosocial interventions for pain management in older adults with dementia: A systematic review of randomized controlled trials.
        J Adv Nurs. 2019; 75: 1608-1620
        • Soysal P.
        • Isik A.T.
        • Stubbs B.
        • et al.
        Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: a systematic review and meta-analysis.
        J Neurol Neurosurg Psychiatry. 2016; 87: 1368-1374
        • Allen V.J.
        • Methven L.
        • Gosney M.A.
        Use of nutritional complete supplements in older adults with dementia: systematic review and meta-analysis of clinical outcomes.
        Clin Nutr. 2013; 32: 950-957